Briya

Briya Competitive Intelligence & Landscape

briya.com ·

Overview

Briya Overview

Briya (briya.com) is a healthcare AI research platform that provides real-time, secure, and frictionless access to patient-level data. The company's core product, AIRE (AI Research Environment), empowers emerging biotech, life sciences, academia, healthcare organizations, and students to conduct research, validate findings, and extract insights from complex medical data. Briya's AI models are purpose-built for clinical complexity, trained on rich, real-world medical data to ensure accuracy and relevance.

Briya's mission is to make healthcare data accessible and easily shareable to drive health innovation. The platform addresses the challenge of siloed datasets by connecting users directly to relevant, real-time datasets globally. It features intelligent collaboration tools, smart visualizations for instant trend identification, and a rigorous analysis process from hypothesis to publication, including built-in validation and peer review preparation. The company is committed to patient privacy and progress, achieving HIPAA Expert Determination for its structured data model.

The Briya platform provides an infrastructure enabling healthcare data retrieval at scale, featuring airtight de-identification, active re-identification prevention, auto-enforced regulation, data ownership management, flawless patient matching, real-time data unification, and rapid onboarding. This ensures that data is de-identified while preserving integrity and accuracy. Briya's goal is to provide access to high-quality medical data quickly, securely, and compliantly through an infrastructure that connects data systems and users without compromising patient identity. The company, also known as Bria Interoperability Ltd., works to overcome challenges in accessing real-world data at scale by unifying, curating, and harmonizing quality data from worldwide partners across healthcare, academic, and commercial sectors.

Briya

Briya Weekly Intel Updates

Receive weekly intel updates about Briya straight to your inbox.

Competitors

Briya Competitors

Among the competitors of Briya, which offers the AIRE healthcare AI research platform, Aetion stands out. Aetion focuses on generating real-world evidence from real-world data, providing a platform for life sciences companies and payers to understand treatment effectiveness and safety. While Briya emphasizes real-time data access and AI-powered research for a broad range of users from students to biotech, Aetion is more concentrated on regulatory-grade evidence generation, potentially offering deeper analytical capabilities for specific clinical and regulatory questions.

Truveta is another significant competitor, known for its extensive dataset of de-identified patient data from numerous health systems. Truveta's key differentiator is the sheer scale and diversity of its data, which can be leveraged for research and insights. In contrast, Briya focuses on connecting users directly to relevant datasets globally in real-time, aiming to break down traditional data silos rather than aggregating a single massive dataset like Truveta. This difference in approach impacts data accessibility and the types of research facilitated.

Innovaccer operates as a healthcare data platform that unifies patient data from various sources to provide a 360-degree view, supporting population health management, value-based care, and patient engagement. While both Innovaccer and Briya deal with data integration in healthcare, Briya is specifically tailored as an AI research environment for hypothesis testing, study design, and collaboration, with a strong emphasis on AI that understands healthcare complexity. Innovaccer's broader platform offers a wider range of solutions beyond pure research, including operational and administrative applications.

Datavant specializes in healthcare data connectivity and interoperability, providing services for health data exchange, record retrieval, and data transformation. Datavant's strength lies in its ability to facilitate secure and efficient data movement across the healthcare ecosystem. While Briya also enables access to all available data and breaks free from silos, its core offering, AIRE, is an AI-powered research platform designed for analysis and insight generation, whereas Datavant's primary focus is on the underlying data logistics and exchange rather than direct research functionalities.

AICURA medical is a technology company providing a platform for data and AI solutions in healthcare and life sciences, integrating multimodal data and utilizing pre-trained AI models for data curation, exploration, and analysis. Similar to Briya, AICURA leverages AI for clinical use cases. However, Briya positions its AIRE platform as a purpose-built AI research environment developed by epidemiologists, emphasizing domain-specific methodologies and guidance, suggesting a more tailored experience for scientific inquiry compared to AICURA's broader data and AI solutions.

Alternatives

Briya Alternatives

Product & Pricing

Briya Product and Pricing Intelligence

Briya (briya.com) offers AIRE, an AI Research Environment designed specifically for healthcare, providing solutions for various stakeholders including emerging biotech, life sciences, academia, healthcare, and students [https://briya.com/]. While a detailed pricing page is not explicitly available, the company emphasizes a flexible approach to accessing their services.

AIRE is available for purchase via the AWS Marketplace, streamlining access for healthcare and life science organizations [https://briya.com/briya-aire-is-now-available-on-aws-marketplace/].

Briya offers a free trial of their AIRE Harmonization Agent, allowing users to instantly access its capabilities to clean, standardize, and harmonize medical data using sample files or their own data, without requiring any coding [https://briya.com/briya-aire-signup/]. This provides a sneak peek into the clinical-grade AI research environment. For other services and specific needs, such as for emerging biotech and life sciences, direct contact for inquiries is suggested [https://briya.com/].

The platform includes key features like Briya Copilot and Briya Explore, which facilitate instant patient data unlocking, smart feedback for research questions, searching structured and unstructured data, and real-time feasibility checks without SQL [https://briya.com/copilot/]. Additionally, Briya Research Rooms provide secure and collaborative data analysis environments, allowing for faster setup and reduced data management time, all with built-in data governance and compliance [https://briya.com/research-rooms/]. These research rooms can be set up on a private cloud server, ensuring data never leaves the hospital's network [https://briya.com/briya-research-rooms-access-lp/].

Hiring & Layoffs

Briya Hiring and Layoffs

Briya is actively hiring, focusing on roles that reinforce its core mission of providing an AI Research Environment (AIRE) for healthcare. The company's career page highlights openings such as Data Engineer and Tech Support Lead [briya.com/careers/]. These positions underscore Briya's commitment to building robust data platforms and scalable systems that manage sensitive health data, as well as providing strong technical support for its advanced AI solutions.

The emphasis on data engineering and technical support indicates a strategic focus on enhancing Briya's data infrastructure and ensuring seamless operation of its AI solutions, which are designed to understand and analyze complex healthcare data [briya.com]. This aligns with the company's objective to break free from traditional data silos and connect users to relevant, real-time datasets globally [briya.com].

While specific details about recent hiring trends in terms of numbers are not publicly available, the job postings and the executive team composition suggest a steady growth trajectory [briya.com/company/]. The executive team includes key roles such as Co-founder & CEO David Lazerson, Co-founder & CTO Guy Tish, Chief Epidemiologist Jonathan Samet, and Executive Director of R&D Elad Itzhakian, all of whom are crucial to advancing Briya's AI-driven research platform [briya.com/company/].

There is no public information available regarding layoffs at Briya. The current hiring patterns for roles like Data Engineer and Tech Support Lead signal a strategic investment in scaling operations, improving data management, and strengthening customer support for its innovative AIRE platform [briya.com/careers/]. This strategy supports Briya's aim to accelerate healthcare research for emerging biotech, life sciences, academia, and healthcare institutions [briya.com].

Leadership

Briya Management and Leadership Team

The leadership team at Briya (briya.com) is spearheaded by its co-founders.

David Lazerson serves as the Co-founder & CEO, and has been actively involved in representing Briya at various industry events, discussing topics such as navigating challenges in the healthcare sector and presenting on accelerating medical innovation with blockchain at conferences like DMEA and The Medtech Conference.

Guy Tish is the Co-founder & CTO, focusing on the unique technology and expert team that drive Briya's platform.

The executive team also includes key medical and research experts.

Jonathan Samet, MD holds the position of Chief Epidemiologist.

Professor Siegal Sadetzki also contributes to Briya's commitment to data integrity as Chief Epidemiology Officer.

Dr. Or Shaked, MD-MPH, is the Director, Medical Research Solutions, and has been a prominent voice on the transformative role of real-world data in medical research. Other vital members include Talia Friedman as Director, Account Management & Data Analysis, and Elad Itzhakian as Executive Director of R&D.

Further strengthening the leadership are Chagai Yariv, the Executive Director of Technical Operations, and Mor Pecht, who leads the company's marketing efforts as Head of Marketing. This diverse team of experts, ranging from medical professionals to technology and operations specialists, collectively contributes to Briya's mission of revolutionizing healthcare AI research.

Financials

Briya Financial Performance, Fundraising, M&A

Information regarding Briya's financial performance, fundraising rounds, valuations, or specific revenue figures is not explicitly available in the provided sources. The company's website focuses on its technological offerings and partnerships rather than detailed financial disclosures.

While specific funding amounts are not mentioned, Briya has attracted seed investors who are proud to support its journey in promoting innovative healthcare by accelerating access to high-quality data. These early investments indicate confidence in Briya's mission to reduce the time to medicine through its platform.

Briya has been recognized in competitive programs, suggesting a positive outlook for its growth and potential. Notably, it was selected as one of five contributors to the Biogen HLTH Rare Disease Accelerator and joined UC Berkeley's prestigious Health Engine as part of its third cohort of promising healthcare startups. These selections highlight Briya's innovative solutions and its potential for impact within the healthcare technology landscape.

The company is positioned at the forefront of healthcare technology, emphasizing real-time, secure, and frictionless access to patient-level data. This infrastructure empowers life science and healthcare organizations globally to expedite the discovery of new treatments, indicating a business model focused on valuable data collaboration services. While direct financial details are not disclosed, its strategic partnerships and platform utility suggest a focus on expanding market presence and user adoption.

Partnerships

Briya Partnerships, Clients and Vendors

Briya's partnerships are central to its mission of providing secure and compliant access to high-quality medical data. The company collaborates with various healthcare organizations, research institutions, and pharmaceutical leaders to accelerate medical research and innovation. One significant collaboration is with MSD, a global pharmaceutical leader, where Briya's Medical Data Retrieval Network was leveraged for in-depth research into three critical diseases [https://briya.com/driving-clinical-innovation-through-real-world-data-briyas-strategic-collaboration-with-msd/].

Briya has also forged a key partnership with Casa Sollievo della Sofferenza, a renowned Italian hospital and research institution, to enhance access to valuable European Real-World Data for researchers worldwide [https://briya.com/expanding-access-to-european-real-world-data-briyas-new-partnership-with-casa-sollievo-della-sofferenza/]. Furthermore, Briya is expanding its healthcare partnerships in Germany, providing secure access to over 11 million de-identified German patient records through its network of trusted healthcare collaborators [https://briya.com/the-gateway-to-german-real-world-data-briya/].

In terms of strategic initiatives, Briya was selected as one of five key contributors to the Biogen HLTH Rare Disease Accelerator. This initiative, led by Biogen and the HLTH Foundation, supports companies that are driving innovation in areas such as diagnosis, treatment, data access, and patient care for rare diseases [https://briya.com/briya-chosen-as-key-contributor-to-biogen-hlth-rare-disease-accelerator/].

Briya's platform, AIRE (AI Research Environment), facilitates collaboration and data sharing, ensuring HIPAA/GDPR compliance and enabling faster publication processes for institutions and researchers [https://briya.com/].

Briya's platform is designed to connect to various data partners, including hospitals, empowering them to unlock the value of their data for research and commercial collaborations at scale [https://briya.com/use-cases/][https://briya.com/healthcare-organizations/]. The company's case studies highlight collaborations with a leading top 10 pharmaceutical company for research into Non-Small Cell Lung Cancer, demonstrating their impact in critical therapeutic areas [https://briya.com/case-studies/]. Through these diverse partnerships, Briya aims to streamline the entire process of accessing and analyzing medical data, removing barriers to research and accelerating innovation [https://briya.com/company/].

Events

Briya Event Participations

Briya actively participates in and hosts various events to connect with the life science and healthcare AI communities. They will be at HLTH EU 2026, showcasing their AIRE platform at Booth D182, where attendees can see interactive demos and meet their experts to learn how they connect clinical data and transform it into actionable insights [briya.com/briya-around-the-world/].

Briya also hosts and participates in numerous webinars. Notable examples include a collaborative webinar with DayOne on 'Data-first, AI-driven decision making for biotech teams' and a discussion titled 'Is AI the New Engine for Life Science Advancement?' featuring Briya Co-Founder and CEO David Lazerson, recorded at the Global BioInnovation Forum [briya.com/resources/], [briya.com/?resource-category=talks], [briya.com/resources/podcast-is-ai-the-new-engine-for-life-science-advancement/].

Community and networking events are also a key focus for Briya. They regularly host networking events for life science professionals, such as their gathering at IMPACCT RWE in Boston, bringing together experts and decision-makers in real-world evidence and research [briya.com/life-science-networking-at-impacct/]. Additionally, Briya's Co-Founder and CEO presented at The Medtech Conference, discussing the decentralized nature of medical data and how blockchain accelerates medical innovation [briya.com/briyas-co-founder-and-ceo-will-present-at-the-medtech-conference/].

Furthermore, Briya engages with accelerators and prestigious programs, demonstrating their commitment to innovation and collaboration. They were selected as a key contributor to the Biogen HLTH Rare Disease Accelerator, an initiative spotlighting companies addressing complex challenges in rare diseases [briya.com/briya-chosen-as-key-contributor-to-biogen-hlth-rare-disease-accelerator/].

Briya also joined UC Berkeley's prestigious Health Engine, an accelerator for early-stage healthcare startups, with the goal of democratizing medical data and expanding access [briya.com/briya-joins-uc-berkeleys-prestigious-health-engine/].

Frequently Asked Questions

What is the strategic significance of Briya's participation in programs like the Biogen HLTH Rare Disease Accelerator and UC Berkeley's Health Engine?

Briya's participation in these accelerators signals a strategic focus on demonstrating innovation, gaining industry validation, and expanding its network within specific high-value healthcare segments. Being selected for the Biogen HLTH Rare Disease Accelerator highlights Briya's potential to address complex challenges in rare diseases, while joining UC Berkeley's Health Engine supports its goal of democratizing medical data and expanding access for early-stage healthcare startups.

What does Briya's current hiring focus on Data Engineer and Tech Support Lead roles imply about its strategic priorities?

Briya's hiring emphasis on Data Engineer and Tech Support Lead roles indicates a strategic investment in strengthening its core data infrastructure and ensuring robust operational support for its AI Research Environment (AIRE) platform. These positions are crucial for building scalable systems to manage sensitive health data, enhancing data quality, and providing seamless technical assistance to users of its advanced AI solutions.

Given the lack of public financial disclosures, what signals indicate Briya's growth and market positioning?

Despite the absence of explicit financial disclosures, Briya's recognition in competitive programs, such as its selection for the Biogen HLTH Rare Disease Accelerator and UC Berkeley's Health Engine, suggests a positive outlook for growth and potential. These competitive selections, along with attracting seed investors, indicate confidence in its innovative solutions for real-time, secure patient-level data access, positioning it at the forefront of healthcare AI technology.

What is the strategic implication of Briya's leadership team including both co-founders and key medical experts like a Chief Epidemiologist and Chief Epidemiology Officer?

The inclusion of both co-founders, David Lazerson (CEO) and Guy Tish (CTO), alongside key medical experts like Chief Epidemiologist Jonathan Samet and Chief Epidemiology Officer Professor Siegal Sadetzki, implies a strategic emphasis on integrating deep medical and epidemiological expertise directly into its AI research platform. This structure suggests a commitment to ensuring data integrity, scientific rigor, and domain-specific methodologies in Briya's AI solutions for healthcare.

How does Briya's approach to data access, focusing on connecting users to global datasets in real-time, differentiate it from competitors like Truveta?

Briya differentiates itself from competitors like Truveta by focusing on connecting users directly to relevant, real-time datasets globally to break down traditional data silos, rather than aggregating a single massive dataset. While Truveta's strength is its vast, aggregated dataset of de-identified patient data, Briya's AI Research Environment (AIRE) emphasizes dynamic access and unification of diverse data sources to facilitate immediate research and insights across a distributed network.

What strategic benefit does Briya gain from offering a free trial of its AIRE Harmonization Agent?

Offering a free trial of its AIRE Harmonization Agent strategically lowers the barrier to entry and allows prospective users to experience the platform's core data standardization capabilities directly. This approach enables potential customers to quickly evaluate the clinical-grade AI research environment's ability to clean and harmonize medical data without coding, facilitating product adoption and demonstrating value upfront for a flexible pricing model.

What does Briya's strategic collaboration with MSD and Casa Sollievo della Sofferenza signify regarding its market expansion?

Briya's strategic collaborations with MSD, a global pharmaceutical leader, and Casa Sollievo della Sofferenza, a renowned Italian hospital, signify its focused market expansion into both pharmaceutical R&D and international healthcare data access. These partnerships enable Briya to drive in-depth research for critical diseases and enhance access to valuable European Real-World Data, broadening its global footprint and utility for researchers worldwide.

Given Briya's engagement in various webinars and networking events, what is its strategic intent for community building?

Briya's active engagement in various webinars and networking events, such as those with DayOne and at IMPACCT RWE, indicates a strategic intent to cultivate and strengthen its community within the life science and healthcare AI sectors. These activities aim to connect with experts, decision-makers, and potential partners, fostering collaboration and positioning Briya as a thought leader in AI-driven healthcare advancements.

How does Briya's focus on HIPAA Expert Determination for its structured data model inform its approach to data privacy and compliance?

Briya's achievement of HIPAA Expert Determination for its structured data model signifies a rigorous and proactive approach to patient privacy and regulatory compliance. This commitment ensures that its platform de-identifies data while preserving integrity, implements active re-identification prevention, and auto-enforces regulations, thereby building trust and enabling secure, compliant access to sensitive medical data for research purposes.

What is the significance of Briya making its AIRE platform available on the AWS Marketplace?

Making its AIRE platform available on the AWS Marketplace signifies a strategic move to streamline procurement and enhance accessibility for healthcare and life science organizations already utilizing AWS infrastructure. This availability facilitates easier adoption, potentially accelerating sales cycles and expanding Briya's reach by integrating into established enterprise cloud ecosystems, while ensuring compliance and security.

Powered by ForesightIQ · Competitive intelligence from digital exhaust